Millendo Therapeutics announces successful merger completion
Millendo Therapeutics announced that the proposed merger with OvaScience has closed, following the approval of OvaScience’s stockholders received on Dec. 4, 2018. The combined company will operate under the name Millendo Therapeutics. December 07, 2018